BEX2 Antikörper (AA 1-128)

Produktnummer ABIN7165127

Produktdetails anti-BEX2 Antikörper

Target: BEX2 (Brain Expressed X-Linked 2 (BEX2))

Bindungsspezifität: AA 1-128

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser BEX2 Antikörper ist unkonjugiert

Applikation: ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)

Kreuzreaktivität: Human

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human Protein BEX2 protein (1-128AA)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Recommended dilution: IHC:1:20-1:200, IF:1:50-1:500,

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu BEX2

Target: BEX2 (Brain Expressed X-Linked 2 (BEX2))

Andere Bezeichnung: BEX2 (BEX2 Produkte)

Synonyme: BEX1 antikoerper, DJ79P11.1 antikoerper, AL024066 antikoerper, Bex1 antikoerper, EG2RVC antikoerper, brain expressed X-linked 2 antikoerper, BEX2 antikoerper, Bex2 antikoerper

Hintergrund:

Background: Regulator of mitochondrial apoptosis and G1 cell cycle in breast cancer. Protects the breast cancer cells against mitochondrial apoptosis and this effect is mediated through the modulation of BCL2 protein family, which involves the positive regulation of anti-apoptotic member BCL2 and the negative regulation of pro-apoptotic members BAD, BAK1 and PUMA. Required for the normal cell cycle progression during G1 in breast cancer cells through the regulation of CCND1 and CDKN1A. Regulates the level of PP2A regulatory subunit B and PP2A phosphatase activity.

Aliases: BEX2Protein BEX2 antibody, Brain-expressed X-linked protein 2 antibody, hBex2 antibody

UniProt: Q9BXY8